检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈逸文 袁慧娟[2] 马书平[2] 杨慧慧[2] 曼华[2] 邓欣如[2] 王丽敏[2] 牛吉攀 付晓梦 苏永 CHEN Yi-wen;YUAN Hui-juan;MA Shu-ping;YANG Hui-hui;MAN Hua;DENG Xin-ru;WANG Li-min;NIU Ji-pan;FU Xiao-meng;SU Yong(The People's Hospital of Henan University,Henan Provincial People's Hospital,Zhenzhou 450003,China)
机构地区:[1]河南大学人民医院(河南省人民医院),郑州450000 [2]河南省人民医院内分泌科,郑州450000
出 处:《医药论坛杂志》2019年第12期51-54,共4页Journal of Medical Forum
摘 要:目的探讨甘精胰岛素在治疗特定2型糖尿病患者时联合SGLT-2抑制剂、DPP-4抑制剂的疗效。方法选取2型糖尿病患者222例,随机分为对照组108例(甘精胰岛素+阿卡波糖),联合组114例(SGLT-2抑制剂+DPP-4抑制剂+甘精胰岛素),两组根据血糖水平调整两组甘精胰岛素剂量,主要终点:糖化血红蛋白(glycated hemoglobin,HbA1c)、空腹血糖(fasting blood glucose)、餐后2 h血糖(2-hour postprandial blood glucose);次要终点:体重指数、腰围臀围、血压、肝功、肾功电解质、血脂、胰岛素日剂量等。结果两组HbAlc、FPG、2 h PG均较治疗前明显下降(P<0.05),联合组在BMI、SBP、DBP、WC、UA、TG、胰岛素日剂量显著降低并且明显低于对照组(P<0.05)。结论甘精胰岛素在治疗特定2型糖尿病患者时联合SGLT-2抑制剂、DPP-4抑制剂,可平稳控制血糖,显著降低胰岛素日剂量、BMI,同时具有减小腰围、降压、降尿酸、调脂作用。Objective To investigate the efficacy of insulin glycyrrhizin combined with SGLT-2 inhibitor and dipeptidyl peptidase-4 inhibitor in the treatment of specific type 2 diabetes mellitus.Methods A total of 222 patients with type 2 diabetes mellitus were randomly divided into control group(n=108)and combination group(n=114)(SGLT-2 inhibitor+DPP-4 inhibitor+insulin glargine).The dose of insulin glargine was adjusted according to the level of blood glucose in the two groups.The main end points were glycosylated hemoglobin(glycated hemoglobin,HbA 1 c),fasting blood glucose(fasting blood glucose)and postprandial blood glucose(2-hour postprandial blood glucose).Secondary endpoints:body mass index,waist circumference and hip circumference,blood pressure,liver function,kidney function and electrolytes,blood lipids,daily dose of insulin,etc.Results HbAlc,FPG and 2hPG in both groups were significantly lower than before treatment(P<0.05),and the daily doses of BMI,SBP,DBP,WC,UA,TG,and insulin in the combined group were significantly lower than those in the control group(P<0.05).Conclusion Insulin glargine combined with SGLT-2 inhibitor and DPP-4 inhibitor in the treatment of specific type 2 diabetic patients can steadily control blood glucose and significantly reduce the daily dosage of insulin.BMI,also has the effects of reducing waist circumference,lowering blood pressure,lowering uric acid and regulating blood lipid.
关 键 词:SGLT-2抑制剂 二肽基肽酶-4抑制剂 甘精胰岛素 特定2型糖尿病
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.22.42.249